Resources

Wearing a CGM on type 2 patients for 3 months improved control…

SGLT-2 inhibitors are a new class of drug for the treatment of type 2 diabetes, but they are also being used off label in patients with type 1 diabetes.

Increased access to healthcare can be beneficial to Medicaid recipients in expansion states…

Daily weight changes may motivate individuals to maintain a healthier lifestyle…

  The first all-in-one pen needle and remover for more convenient needle change. Unifine Pentips Plus is the world’s first integrated pen needle system that uses the same high quality needles as Unifine Pentips, but also features an integrated needle disposal chamber. Convenient and easy to use, this system encourages …

When traveling, “nearby” may mean closer than you think. A patient of mine, 35 years of age, with type 1 diabetes, boarded a plane. As recommended, she took her supplies, food, and treatment for a low with her in her carry-on bag. She had a window seat. She did not …

Risk of hospitalization, early death doubled in type 2 patients… Cardiovascular complications have been linked to diabetes. However, according Dr. Timothy Davis from University of Western Australia, “there have been no detailed contemporary population-based studies of heart failure (HF) complicating type 2 diabetes.” In an effort to investigate predictors and …

Type 1 diabetes patients had a 30% higher risk of dying within six years after more than four hospitalizations for diabetic ketoacidosis…

A clinical trial to investigate whether repeated injections of the tuberculosis vaccine bacille Calmette-Guérin holds promise… The researchers announced the start of their phase 2 trial at the American Diabetes Association (ADA) 75th Scientific Sessions in Boston. Study author Denise Faustman, MD, director of the immunobiology laboratory at Massachusetts General …

No significant difference in incidence of infections, cancer, renal failure, or severe hypoglycemia… In patients with type 2 diabetes and cardiovascular disease, the use of sitagliptin (Januvia, Merck), a dipeptidyl peptidase-4 (DPP-4) inhibitor used to lower HbA1c levels, is not associated with an increased risk of cardiovascular events, according to …